Intracerebral Peripheral Blood Stem Cell (CD34+) Implantation Induces Neuroplasticity by Enhancing β1 Integrin-Mediated Angiogenesis in Chronic Stroke Rats
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Although stem cell-based treatments for stroke and other neurodegenerative diseases have advanced rapidly, there are still few clinical treatments available. In this study, rats receiving intracerebral peripheral blood hematopoietic stem cell (CD34+) (PBSC) transplantation showed much more improvement in neurological function after chronic cerebral ischemia in comparison with vehicle-treated control rats. Using laser-scanning confocal microscopy, implanted PBSCs were seen to differentiate into glial cells [GFAP+(glial fibrillary acidic protein-positive)], neurons [Nestin+, MAP-2+(microtubule-associated protein 2-positive), Neu-N+(neuronal nuclear antigen-positive)], and vascular endothelial cells [vWF+(von Willebrand factor-positive)], thereby enhancing neuroplastic effects in the ischemic brain. Cortical neuronal activity, as evaluated by 1 H-MRS (proton magnetic resonance spectroscopy), also increased considerably in PBSC-treated rats compared with a vehicle-treated control group. In addition, PBSC implantation promoted the formation of new vessels, thereby increasing the local cortical blood flow in the ischemic hemisphere. These observations may be explained by the involvement of stem cell-derived macrophage/microglial cells, and β1 integrin expression, which might enhance this angiogenic architecture over the ischemic brain. Furthermore, quantitative reverse transcription-PCR analysis showed significantly increased modulation of neurotrophic factor expression in the ischemic hemisphere of the PBSC-transplanted rats compared with vehicle-treated control rats. Thus, intracerebral PBSC transplantation might have potential as a therapeutic strategy for treating cerebrovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“Mononuclear cells (MNCs) were isolated from peripheral blood using the Ficoll-Histopaque (Sigma, St. Louis, MO) centrifugation method (Asahara et al., 1997).”
MethodMarrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629 · cited 3×
“For example, adult bone marrow contains mesenchymal stem cells (MSCs) or stromal cells, which can potentially differentiate into a variety of cell types such as adipocytes, chondrocytes, and myoblasts (Prockop, 1997; Dennis and Charbord, 2002).”
BackgroundMobilized bone marrow cells repair the infarcted heart, improving function and survival
Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., & Anversa, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181177898 · Cited by 2,086 · cited 2×
“Furthermore, PBSCs have already been used in transplantation for the regeneration of nonhematopoietic tissues, such as skeletal muscle, heart (Orlic et al., 2001), and neurons (Sigurjonsson et al.”
BackgroundMesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613 · cited 2×
“Human umbilical cord blood (hUCB) (Prockop, 1997; Erices et al., 2000) has also been shown to contain large numbers of hematopoietic colony-forming cells (Nakahata and Ogawa, 1982).”
BackgroundG-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332 · cited 2×
“tor 4 (CXCR4) is a strong chemoattractant for CD34 cells and also plays an important role in HSC trafficking between peripheral circulation and bone marrow (Petit et al., 2002).”
BackgroundJohe, K. K., Hazel, T. G., Muller, T., Dugich-Djordjevic, M. M., & McKay, R. D. (1996) · Genes & Development · doi:10.1101/gad.10.24.3129 · Cited by 1,154 · cited 2×
“…and angiogenesis might include enhanced production of trophic factors such as BDNF (Leventhal et al., 1999; Borlongan et al., 2004) and PDGF (Johe et al., 1996) by CD34 cell-derived neovasculatures, and directly result in differentiation of these CD34 stem cells into neuron/glial cells (Hao…”
BackgroundGranulocyte colony-stimulating factor and its receptor
Demetri, G., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,064 · cited 1×
“DOI:10.1523/JNEUROSCI.5165-05.2006 Copyright © 2006 Society for Neuroscience 0270-6474/06/263444-10$15.00/0 bone marrow (Demetri and Griffin, 1991), thus amplifying the concentration of PBSCs.”
BackgroundInfluentialWilliams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055 · cited 2×
“…in this study, interaction of transplanted PBSCs with injured brain tissue may lead PBSCs and/or parenchymal cells to produce trophic factors (Lachmund et al., 1994) including SDF-1 that may contribute to the recovery of neural functions lost as a result of tissue injury (Williams et al., 1986).”
BackgroundStem cell therapy for human neurodegenerative disorders–how to make it work
Lindvall, O., Kokaia, Z., & Martinez-Serrano, A. (2004) · Nature Medicine · doi:10.1038/nm1064 · Cited by 915 · cited 1×
“Because neuronal death is the major pathogenetic mechanism in neurodegenerative diseases such as cerebrovascular disease, stem cell therapy has been proposed as an effective “regenerative” approach (Lindvall et al., 2004; Taguchi et al., 2004).”
BackgroundAdministration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model
Taguchi, A., Soma, T., Tanaka, H., Kanda, T., Nishimura, H., Yoshikawa, H., Tsukamoto, Y., Iso, H., Fujimori, Y., Stern, D. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420622 · Cited by 784
Cited by
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
“, 1986) or von Willebrand factor (vWF; an endothelial cell marker; Shyu et al., 2006) and anti-Aβ40 antibody.”
BackgroundCell transplantation therapy for stroke
Bliss, T., Guzman, R., Daadi, M., & Steinberg, G. K. (2007) · Stroke · doi:10.1161/01.str.0000247888.25985.62 · Cited by 374
Kim, H. Y., Kim, T. J., Kang, L., Kim, Y.-J., Kang, M. K., Kim, J., Ryu, J. H., Hyeon, T., Yoon, B.-W., Ko, S.-B., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119942 · Cited by 321
Endothelial progenitor cell transplantation improves long‐term stroke outcome in mice
Fan, Y., Shen, F., Frenzel, T., Zhu, W., Ye, J., Liu, J., Chen, Y., Su, H., Young, W. L., & Yang, G. (2010) · Annals of Neurology · doi:10.1002/ana.21919 · Cited by 289
Horie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., Shamloo, M., Hamilton, S. A., Jiang, K., Huhn, S., et al. (2011) · Stem Cells · doi:10.1002/stem.584 · Cited by 240
Stem cells for ischemic brain injury: A critical review
Burns, T. C., Verfaillie, C. M., & Low, W. C. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22038 · Cited by 207
“These data, however, have often been based on morphological criteria in vitro (Woodbury et al., 2000; Deng et al., 2001) and in vivo studies employing transferable labels (Kopen et al., 1999; Chen et al., 2000, Li et al., 2001; Munoz-Elias et al., 2004; Shyu et al., 2006).”
BackgroundJung, D.-I., Ha, J., Kang, B.-T., Kim, J.-W., Quan, F.-S., Lee, J.-H., Woo, E.-J., & Park, H.-M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.05.027 · Cited by 169
“According to prior reports, SDF-1 can promote the survival of neurons and help support neurons that have been damaged by injury or inflammation [3,9,18].”
InfluentialExosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159
Self-citationBalistreri, C. R., Buffa, S., Pisano, C., Lio, D., Ruvolo, G., & Mazzesi, G. (2015) · BioMed Research International · doi:10.1155/2015/835934 · Cited by 76
Metadata
- Authors
- Shyu, W.-C., Lin, S.-Z., Chiang, M.-F., Su, C.-Y., & Li, H.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-03-29
- Volume
- 26
- Issue
- 13
- Pages
- 3444-3453
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1998412056
- Cited by
- 169
- References
- 45
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.